Maternal predictors of intrauterine growth restriction

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 16, Issue 3, 2013, Pages 310-319

  Cetin, Irene ^a   Mandò, Chiara ^a   Calabrese, Stefania ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

environmental factors; epigenetics; intrauterine growth restriction; markers and predictors; nutritional status

Indexed keywords

HOMOCYSTEINE; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

AIR POLLUTANT; ALCOHOL CONSUMPTION; BODY MASS; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FETUS GROWTH; FOOD CONTAMINATION; GENE EXPRESSION; GENETIC PREDISPOSITION; GENOTYPE ENVIRONMENT INTERACTION; HIGH RISK PREGNANCY; HUMAN; INHERITANCE; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MATERNAL CARE; MATERNAL NUTRITION; OBESITY; OVERNUTRITION; PLACENTA; PLACENTA FUNCTION; PREGNANCY OUTCOME; REVIEW; SMOKING; SOCIAL ASPECT; WEIGHT GAIN;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MICRORNAS; NUTRITIONAL STATUS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84876406599     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32835e8d9c     Document Type: Review

References (84)

1. Cetin I, Alvino G. Intrauterine growth restriction: implications for placental metabolism and transport. A review Placenta 2009; 30 (Suppl A):S77-S82.
2. Mandò C, Tabano S, Colapietro P, et al. Transferrin receptor gene and protein expression and localization in human IUGR and normal term placentas. Placenta 2011; 32:44-50.
3. Furness D, Fenech M, Dekker G, et al. Vitamin B12, Vitamin B6 and homocysteine: impact on pregnancy outcome. Matern Child Nutr 2011. doi: 10.1111/j.1740-8709.2011.00364.x.
4. Tanentsapf I, Heitmann BL, Adegboye AR. Systematic review of clinical trials on dietary interventions to prevent excessive weight gain during pregnancy among normal weight, overweight and obese women. BMC Pregnancy Childbirth 2011; 11:81.
5. Wu G, Imhoff-Kunsch B, Girard AW. Biological mechanisms for nutritional regulation of maternal health and fetal development. Paediatr Perinat Epidemiol 2012; 26 (Suppl 1):4-26.
6. Alfaradhi MZ and Ozanne SE. Developmental programming in response to maternal overnutrition. Front Gene 2011; 2: 27. doi:10.3389/fgene.2011.00027.
7. Berti C, Biesalski HK, Gärtner R, et al. Micronutrients in pregnancy: current knowledge and unresolved questions. Clin Nutr 2011; 30:689-701.
8. Berti C, Cetin I, Agostoni C, et al. Pregnancy and infants'outcome: nutritional and metabolic implications. Crit Rev food Sci Nutr (in press).
9. Cetin I, Berti C, Calabrese S. Role of micronutrients in the periconceptional period. Hum Reprod Update 2010; 16:80-95.
10. Patrelli TS, Dall'asta A, Gizzo S, et al. Calcium supplementation and prevention of preeclampsia: a meta-analysis. J Mat Fet Neon Med 2012; 25:2570-2574.
11. Catov JM, Bodnar LM, Olsen J, et al. Periconceptional multivitamin use and risk of preterm or small-for-gestational-age births in the Danish National Birth Cohort. Am J Clin Nutr 2011; 94:906-912.
12. Coan PM, Vaughan OR, Sekita Y, et al. Adaptations in placental phenotype support fetal growth during undernutrition of pregnant mice. J Physiol 2010; 588:527-538.
13. Fowden AL, Ward JW, Wooding FBP, et al.A. J. Developmental programming of the ovine placenta. Soc Reprod Fertil 2010:67:41-57.
14. Vaughan OR, Sferruzzi-Perri AN, Coan PM, et al. Environmental regulation of placental phenotype: implications for fetal growth. Reprod Fertil Dev 2012;24:80-96.
15. Belkacemi L, Jelks A, Chen CH, et al. Altered placental development in undernourished rats: role of maternal glucocorticoids. Reprod Biol Endocrinol 2011; 9:105.
16. Igwebuike UM. Impact of maternal nutrition on ovine foetoplacental development: a review of the role of insulin-like growth factors. Anim Reprod Sci 2010; 121:189-196.
17. Imdad A, Bhutta ZA. Maternal nutrition and birth outcomes: effect of balanced protein-energy supplementation. Paediatr Perinat Epidemiol 2012; 26 (Suppl 1):178-190.
18. McKnight JR, Satterfield MC, Li X, et al. Obesity in pregnancy: problems and potential solutions. Front Biosci (Elite Ed) 2011; 3:442-452; Review.
19. Luzzo KM, Wang Q, Purcell SH, et al. High fat diet induced developmental defects in the mouse: oocyte meiotic aneuploidy and fetal growth retardation/brain defects. PLoS One 2012; 7:e49217.
20. Moran LJ, Sui Z, Cramp CS, Dodd JM. A decrease in diet quality occurs during pregnancy in overweight and obese women which is maintained postpartum. Int J Obes (Lond) 2012. doi: 10.1038/ijo.2012.129
21. Josefson JL, Feinglass J, Rademaker AW, et al. Maternal obesity and vitamin D sufficiency are associated with cord blood vitamin D insufficiency. J Clin Endocrinol Metab 2013; 98:114-119.
22. Kim H, Hwang JY, Kim KN, et al. Relationship between body-mass index and serum folate concentrations in pregnant women. Eur J Clin Nutr 2012;66:136-138.
23. Dao MC, Sen S, Iyer C, et al. Obesity during pregnancy and fetal iron status: is Hepcidin the link? J Perinatol 2012. doi: 10.1038/jp.2012.81
24. Schaeffler A, Gross P, Buettner R, et al. Fatty acid-induced induction of Tolllike receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity. Immunology 2009; 126:233-245.
25. Zhu MJ, Du M, Nathanielsz PW, Ford SP. Maternal obesity up-regulates inflammatory signaling pathways and enhances cytokine expression in the mid-gestation sheep placenta. Placenta 2010; 31:387-391.
26. Cetin I, Parisi F, Berti C, et al. Placental fatty acid transport in maternal obesity. JDOHAD 2012; 3:409-414.
27. Yamada H, Sata F, Saijo Y, et al. Genetic factors in fetal growth restriction and miscarriage. Semin Thromb Hemost 2005; 31:334-345.
28. Edwards DR, Romero R, Kusanovic JP, et al. Polymorphisms in maternal and fetal genes encoding for proteins involved in extracellular matrix metabolism alter the risk for small-for-gestational-age. J Matern Fetal Neonatal Med 2011; 24:362-380.
29. Chelbi ST, Wilson ML, Veillard AC, et al. Genetic and epigenetic mechanisms collaborate to control SERPINA3 expression and its association with placental diseases. Hum Mol Genet 2012; 21:1968-1978.
30. McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 2005; 85:571-633.
31. Novakovic B, Saffery R. The ever growing complexity of placental epigenetics-Role in adverse pregnancy outcomes and fetal programming. Placenta 2012; 33:959-970.
32. Koukoura O, Sifakis S, Soufla G, et al. Loss of imprinting and aberrant methylation of IGF2 in placentas from pregnancies complicated with fetal growth restriction. Int J Mol Med 2011; 28:481-487.
33. Koukoura O, Sifakis S, Zaravinos A, et al. Hypomethylation along with increased H19 expression in placentas from pregnancies complicated with fetal growth restriction. Placenta 2011; 32:51-57.
34. Lambertini L, Lee TL, Chan WY, et al. Differential methylation of imprinted genes in growth-restricted placentas. Reprod Sci 2011; 18:1111-1117.
35. Banister CE, Koestler DC, Maccani MA, et al. Infant growth restriction is associated with distinct patterns of DNA methylation in human placentas. Epigenetics Off J DNA Methylation Soc 2011; 6:920e7.
36. Mouillet JF, Chu T, Hubel CA, et al. The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction. Placenta 2010; 31:781-784.
37. Hromadnikova I, Kotlabova K, Doucha J, et al. Absolute and relative quantification of placenta-specific micrornas in maternal circulation with placental insufficiency-related complications. J Mol Diagn 2012; 14:160-167.
38. Pinney SE, Jaeckle Santos LJ, Han Y, et al. Exendin-4 increases histone acetylase activity and reverses epigenetic modifications that silence Pdx1 in the intrauterine growth retarded rat. Diabetologia 2011; 54:2606-2614.
39. Sohi G, Marchand K, Revesz A, et al. Maternal protein restriction elevates cholesterol in adult rat offspring due to repressive changes in histone modifications at the cholesterol 7alpha-hydroxylase promoter. Mol Endocrinol 2011; 25:785-798.
40. Sebert S, Sharkey D, Budge H, et al. The early programming of metabolic health: is epigenetic setting the missing link? Am J Clin Nutr 2011; 94(Suppl):1953S-1958S.
41. Wang J, Wu Z, Li D, et al. Nutrition, epigenetics, and metabolic syndrome. Antioxid Redox Signal 2012; 17:282-301.
42. Sundrani DP, Chavan Gautam PM, Mehendale SS, et al. Altered metabolism of maternal micronutrients and omega 3 fatty acids epigenetically regulate matrix metalloproteinases in preterm pregnancy: a novel hypothesis. Med Hypotheses 2011; 77:878e83.
43. Jiang X, Yan J, West AA, et al. Maternal choline intake alters the epigenetic state of fetal cortisol-regulating genes in humans. Faseb J 2012;26:3563e74.
44. Zeng Y, Gu P, Liu K, et al. Maternal protein restriction in rats leads to reduced PGC-1alpha expression via altered DNA methylation in skeletal muscle. Mol Med Report 2013; 7:306-312.
45. Gao H, Yallampalli U, Yallampalli C. Maternal protein restriction reduces expression of angiotensin I-converting enzyme 2 in rat placental labyrinth zone in late pregnancy. Biol Reprod 2012; 86:31.
46. Gao H, Yallampalli U, Yallampalli C. Protein restriction to pregnant rats increases the plasma levels of angiotensin II and expression of angiotensin II receptors in uterine arteries. Biol Reprod 2012; 86:68.
47. Lattuada D, Colleoni F, Martinelli A, et al. Higher mitochondrial DNA content in human IUGR placenta. Placenta 2008; 29:1029-1033.
48. Colleoni F, Lattuada D, Garretto A, et al. Maternal blood mitochondrial DNA content during normal and intrauterine growth restricted (IUGR) pregnancy. Am J Obstet Gynecol 2010; 203:365.e1-6.
49. Patra J, Bakker R, Irving H, et al. Dose-response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA)-a systematic review and meta-analyses. BJOG 2011; 118:1411-1421.
50. Wilhelm-Benartzi CS, Houseman EA, Maccani MA, et al. In utero exposures, infant growth, and DNA methylation of repetitive elements and developmentally related genes in human placenta. Environ Health Perspect 2012;120:296e302.
51. Miranda RC, Pietrzykowski AZ, Tang Y, et al. MicroRNAs: master regulators of ethanol abuse and toxicity? Alcohol Clin Exp Res 2010; 34:575-587.
52. Soares AR, Pereira PM, Ferreira V, et al. Ethanol exposure induces upregulation of specific microRNAs in zebrafish embryos. Toxicol Sci 2012; 127:18-28.
53. Downing C, Johnson TE, Larson C, et al. Subtle decreases in DNA methyla-tion and gene expression at the mouse Igf2 locus following prenatal alcohol exposure: effects of a methyl-supplemented diet. Alcohol (Fayetteville, NY) 2011; 45:65e71.
54. Mason S, Anthony B, Lai X, et al. Ethanol exposure alters protein expression in a mouse model of fetal alcohol spectrum disorders. Int J Proteomics 2012; 2012:867141.
55. Han M, Neves AL, Serrano M, et al. Effects of alcohol, lithium, and homo-cysteine on nonmuscle myosin-II in the mouse placenta and human tropho-blasts. Am J Obstet Gynecol 2012; 207:140.e7-19.
56. Krstev S, Marinković J, Simić S, et al. The influence of maternal smoking and exposure to residential ETS on pregnancy outcomes: a retrospective national study. Matern Child Health J 2012 [Epub ahead of print]. doi: 10.1007/s10995-012-1169-6.
57. Suter MA, Aagaard K. What changes in DNA methylation take place in individuals exposed to maternal smoking in utero? Epigenomics 2012; 4:115-118.
58. Suter M, Abramovici A, Showalter L, et al. In utero tobacco exposure epigenetically modifies placental CYP1A1 expression. Metabolism 2010; 59:1481e90.
59. Joubert BR, Ha°berg SE, Nilsen RM, et al. 450K Epigenome-Wide Scan Identifies Differential DNA Methylation in Newborns Related to Maternal Smoking during Pregnancy. Environ Health Perspect 2012; 120:1425-1431.
60. Suter M, Ma J, Harris AS, et al. Maternal tobacco use modestly alters correlated epigenome-wide placental DNA methylation and gene expression. Epigenetics Off J DNA Methylation Soc 2011; 6:1284-1294.
61. Maccani MA, Avissar-Whiting M, Banister CE, et al. Maternal cigarette smoking during pregnancy is associated with downregulation of miR-16, miR-21, and miR-146a in the placenta. Epigenetics Off J DNA Methylation Soc 2010; 5:583e9.
62. Kovatsi L, Fragou D, Samanidou V, et al. Drugs of abuse: epigenetic mechanisms in toxicity and addiction. Curr Med Chem 2011; 18:1765e74.
63. Stieb DM, Chen L, Eshoul M, et al. Ambient air pollution, birth weight and preterm birth:asystematic reviewandmeta-analysis. Environ Res 2012;117:100-111.
64. Ghosh JK, Wilhelm M, Su J, et al. Assessing the influence of traffic-related air pollution on risk of term low birth weight on the basis of land-use-based regression models and measures of air toxics. Am J Epidemiol 2012; 175:1262-1274.
65. Darrow LA, Klein M, Strickland MJ, et al. Ambient air pollution and birth weight in full-term infants in Atlanta, 1994-2000. Environ Health Perspect 2011; 119:731-737.
66. Pacheco KA. Epigenetics mediate environment: gene effects on occupational sensitization. Curr Opin Allergy Clin Immunol 2012; 12:111-118.
67. Sharma E, Mustafa M, Pathak R, et al. A case control study of gene environmental interaction in fetal growth restriction with special reference to organo-chlorine pesticides. Eur J Obstet Gynecol Reprod Biol 2012; 161:163-169.
68. Lee BE, Hong YC, Park H, et al. Interaction between GSTM1/GSTT1 polymorphism and blood mercury on birth weight. Environ Health Perspect 2010; 118:437-443.
69. Kippler M, Tofail F, Gardner R, et al. Maternal cadmium exposure during pregnancy and size at birth: a prospective cohort study. Environ Health Perspect 2012; 120:284-289.
70. Doi T, Puri P, McCann A, et al. Epigenetic effect ofcadmium on globalde novo DNA hypomethylation in the cadmium-induced ventral body wall defect (VBWD) in the chick model. Toxicol Sci 2011; 120:475-480.
71. Castillo P, Ibánez F, Guajardo A, et al. Impact of cadmium exposure during pregnancy on hepatic glucocorticoid receptor methylation and expression in rat fetus. PLoS One 2012; 7:e44139.
72. Pattenden S, Casson K, Cook S, et al. Geographical variation in infant mortality, stillbirth and low birth weight in Northern Ireland, 1992-2002. J Epidemiol Community Health 2011; 65:1159-1165.
73. Silverman JG, Decker MR, Reed E, et al. Intimate partner violence victimization prior to and during pregnancy among women residing in 26 US states: associations with maternal and neonatal health. Am J Obstet Gynecol 2006; 195:140-148.
74. Hosseini SM, Biglan MW, Larkby C, et al. Trait anxiety in pregnant women predicts offspring birth outcomes. Paediatr Perinatal Epidemiol 2009; 23:557-566.
75. Brown SJ, Yelland JS, Sutherland GA, et al. Stressful life events, social health issues and low birthweight in an Australian population-based birth cohort: challenges and opportunities in antenatal care. BMC Public Health 2011; 11:196.
76. Cetin I, Huppertz B, Burton G, et al. Pregenesys preeclampsia markers consensus meeting: What dowerequire from markers, risk assessment and model systems to tailor preventive strategies? Placenta 2011; 32:S4-S16.
77. Kaymaz C, Demir A, Bige O, et al. Analysis of perinatal outcome by combination of first trimester maternal plasma homocysteine with uterine artery Doppler velocimetry. Prenat Diagn 2011; 31:1246-1250.
78. Qiu Q, Bell M, Lu X, et al. Significance of IGFBP-4 in the development of fetal growth restriction. J Clin Endocrinol Metab 2012; 97:E1429-E1439.
79. Odibo AO, Zhong Y, Longtine M, et al. First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction. Placenta 2011; 32:333-338.
80. Asvold BO, Vatten LJ, Romundstad PR, et al. Angiogenic factors in maternal circulation and the risk of severe fetal growth restriction. Am J Epidemiol 2011; 173:630-639.
81. Favretto D, Cosmi E, Ragazzi E, et al. Cord blood metabolomic profiling in intrauterine growth restriction. Anal Bioanal Chem 2012; 402:1109-1121.
82. Lin G, Liu C, Feng C, et al. Metabolomic analysis reveals differences in umbilical vein plasma metabolites between normal and growth-restricted fetal pigs during late gestation. J Nutr 2012; 142:990-998.
83. Dess̀i A, Atzori L, Noto A, et al. Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome. J Matern Fetal Neonatal Med 2011; 24 (Suppl 2):35-39.
84. Dess̀i A, Ottonello G, Fanos V. Physiopathology of intrauterine growth retardation: from classic data to metabolomics. J Matern Fetal Neonatal Med 2012; 25 (Suppl 5):13-18.